Therapy with Mesenchymal Stem Cells Obtained Using the Rigenera® System for the Treatment of Feline Chronic Gingivostomatitis
Cats; Autologous micrografts; Regenerative dentistry.
Feline Chronic Gingivostomatitis accounts for approximately 72% of dental diagnoses in cats. Its treatment remains a major challenge for veterinarians, as there is still no effective therapeutic protocol available. The present study aimed to evaluate the efficacy of mesenchymal stem cells derived from feline dental pulp using the Rigenera® system in the treatment of cats with chronic gingivostomatitis. Twenty cats, both male and female, of different breeds, aged between 4 and 8 years, presenting with oral lesions diagnosed as chronic gingivostomatitis, were selected and divided into two groups. One group underwent conventional surgical treatment with tooth extraction, while the other group received micrografts rich in stem cells, obtained with the Rigenera® system. The results indicate that the use of micrografts rich in autologous mesenchymal stem cells has potential as a therapeutic option for feline chronic gingivostomatitis.